332081-60-4 Usage
Uses
Used in Chemical and Biological Research:
DEAB is utilized as a reagent in chemical and biological research for its capacity to inhibit aldehyde dehydrogenase enzymes, which is crucial for understanding the fundamental processes of cell proliferation and differentiation.
Used in Cancer Biology Research:
In the field of cancer biology, DEAB is employed as a research tool to explore the mechanisms of tumorigenesis and development due to its inhibitory effects on aldehyde dehydrogenase enzymes, which are implicated in these processes.
Used in Drug Development for Cancer Treatment:
DEAB is being investigated as a potential drug candidate for the treatment of certain types of cancer, leveraging its ability to modulate cell proliferation and differentiation through the inhibition of aldehyde dehydrogenase enzymes.
Used in Pharmaceutical Industry:
Within the pharmaceutical industry, DEAB is considered for its potential application in developing new therapeutics targeting cancer, given its demonstrated biological activities and the need for novel cancer treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 332081-60-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,2,0,8 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 332081-60:
(8*3)+(7*3)+(6*2)+(5*0)+(4*8)+(3*1)+(2*6)+(1*0)=104
104 % 10 = 4
So 332081-60-4 is a valid CAS Registry Number.
332081-60-4Relevant articles and documents
New synthesis of oxcarbazepine via remote metalation of protected N-o-tolyl-anthranilamide derivatives
Lohse, Olivier,Beutler, Ulrich,Fünfschilling, Peter,Furet, Pascal,France, Julien,Kaufmann, Daniel,Penn, Gerhard,Zaugg, Werner
, p. 385 - 389 (2007/10/03)
Benzyl and allyl protected N-o-tolyl-anthranilamides were efficiently prepared by Buchwald-Hartwig C-N cross coupling reactions, followed by protection of the amino group. Under directed remote metalation conditions, protected dibenzoazepinones were obtained in good yields. Deprotection of the amine and conversion to an urea furnished a new and efficient synthesis of the antiepileptic drug Trileptal.
